LIBRITABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Libritabs, and what generic alternatives are available?
Libritabs is a drug marketed by Valeant Pharm Intl and is included in three NDAs.
The generic ingredient in LIBRITABS is chlordiazepoxide. There are nine drug master file entries for this compound. Additional details are available on the chlordiazepoxide profile page.
Summary for LIBRITABS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Patent Applications: | 4,008 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIBRITABS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LIBRITABS
US Patents and Regulatory Information for LIBRITABS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085482-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085481-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |